Novo Nordisk shares dive 9% after heart medicine fails trial

Thread starter International: Top News And Analysis
Start date Friday at 1:02 PM

International: Top News And Analysis

Guest

Friday at 1:02 PM

The experimental medicine ziltivekimab didn't translate into a statistically meaningful reduction in major cardiovascular adverse events, Novo said Friday.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Novo Nordisk shares dive 9% after heart medicine fails trial

Prefix: N/A

Forum: World News

Start date: Friday at 1:02 PM

Last reply date: Friday at 1:02 PM

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Friday at 1:02 PM

Replies: 0

Views: 5

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search